Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to evaluate the safety and pharmacokinetics of redosing EXPAREL via local subcutaneous infiltration in healthy volunteers.

Key facts

Study ID
NCT02210247
Run by
Pacira Pharmaceuticals, Inc
People needed
60
Starts
2014-08-01
Expected to finish
2014-09-01
Last updated by the study team
2021-07-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.